BEAC or BEAM for High-dose Therapy in Patients with Non-Hodgkin's Lymphoma? A Single Centre Analysis on Toxicity and Efficacy

References

• Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. and Chauvin, F. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine 333, 1540–1545.
   PubMed Web of Science ®Google Scholar
• Verdonck, L.F., van Putten, W.L.J., Hagenbeek, A., Schouten, H.C., Sonneveld, P., van Imhoff, G.W., Kluin-Nelemans, H.C., Raemaekers, J.M.M., van Oers, R.H.J., Haak, H.L., Shots, R., Dekker, A.W., de Gast, G.C. and Löwenberg, B. (1995) "Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma", New England Journal of Medicine 332, 1045–1051.
   PubMed Web of Science ®Google Scholar
• Martelli, M., Vignetti, M., Zinzani, EL., Gherlinzoni, F., Meloni, G., Fiacchini, M., De Sanctis, V, Papa, G., Martelli, M.F., Calabresi, F., Tura, S. and Mandelli, F. (1996) "High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized Italian multicenter study", Journal of Clinical Oncology 14, 534–542.
   PubMed Web of Science ®Google Scholar
• Pettengell, R., Radford, J.A., Morgenstern, G.R., Scarffe, J.H., Harris, M., Woll, P.J., Deakin, D.P., Ryder, D., Wilkinson, P.M. and Crowther, D. (1996) "Survival benefit from high-dose therapy with autologous blood progenitor cell transplantation in poor-prognosis non-Hodgkin's lymphoma", Journal of Clinical Oncology 14, 586–592.
   PubMed Web of Science ®Google Scholar
• Gianni, A.M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P. and Bonadonna, G. (1997) "High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma", New England Journal of Medicine 336, 1290–1297.
   PubMed Web of Science ®Google Scholar
• Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y, Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P. and Reyes, E (1997) "Benefit of autologous bone-marrow transplantation in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2", Journal of Clinical Oncology 15, 1131–1137.
   PubMed Web of Science ®Google Scholar
• Santini, G., Salvagno, L., Leoni, P., Chisesi, T., De Souza, C., Sertoli, M.R., Rubagotti, A., Congiu, A.M., Centurioni, R., Olivieri, A., Tedeschi, L., Vespignani, M., Nati, S., Soracco, M., Porcellini, A., Contu, A., Guarnaccia, C., Pescosta, N., Majolino, I., Spriano, M., Vimercati, R., Rossi, E., Zambaldi, G., Mangoni, L., Endrizzi, L., Sileni, V.C., Miggiano, M.C., Marino, G., Damasio, E. and Rizzoli, V. (1998) "VACOP-B versus VACOP-B plus autologous bone-marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the Non-Hodgkin's Lymphoma Cooperative Study Group", Journal of Clinical Oncology. 16, 2796–2802.
   PubMed Web of Science ®Google Scholar
• Mounier, N. and Gisselbrecht, C. (1998) "Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma", Annals of Oncology 9\(Suppl. 1), S15—S21.
   PubMedGoogle Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Miller, A.B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981) "Reporting results of cancer treatment", Cancer 47, 207–214.
   PubMed Web of Science ®Google Scholar
• Gratwohl, A., Baldomero, H., Horisberger, B., Schmid, C., Passweg, J. and Urbano-Ispizua, A. (2002) "Current trends in hematopoietic stem cell transplantation in Europe", Blood 100, 2374–2386.
   PubMed Web of Science ®Google Scholar
• Samuels, B.I. and Bitran, J.D. (1995) "High-dose intravenous melphalan: a review", Journal of Clinical Oncology. 13, 1786–1799.
   PubMed Web of Science ®Google Scholar
• Wardley, A.M., Jayson, G.G., Swindell, R., Morgenstern, G.R., Chang, J., Bloor, R., Fraser, C.J. and Scarffe, J.H. (2000) "Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue", British Journal of Haematology 110, 292–299.
   PubMed Web of Science ®Google Scholar
• Caballero, M.D., Rubio, V, Rifon, J., Heras, I., Garcia-Sanz, R., Vazquez, L., Vidriales, B., del Canizo, MC., Corral, M., Gonzales, M., Leon, A., Jean-Paul, E., Rocha, E., Moraleda, J.M. and San Miguel, J.F. (1997) "BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors", Bone Marrow Transplan-tation 20,451–458.
   PubMed Web of Science ®Google Scholar
• Jantunen, E., Mahlamäki, E. and Nousiainen, T. (2000) "Feasibility and toxicity associated with high-dose chemotherapy supported by peripheral blood progenitor cell transplantation in elderly (>60 yrs) lymphoma patients: comparison with patients 60 yrs treated with the same protocol", Bone Marrow Transplantation 26, 737–741.
   PubMed Web of Science ®Google Scholar
• Rapoport, A.P. Miller Watelet, L.F., Linder, T., Eberly, S., Raubertas, RE, Lipp, J., Duerst R., Abboud, C.N., Constine, L., Andrews, J., Etter, MA., Spear, L., Powley, E., Packman, C.H., Rowe, J.M., Schwertschlag, U., Bedrosian, C. and Liesweld, J.L. (1999) "Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants", Journal of Clinical Oncology 17, 2446–2463.
   Google Scholar
• Weaver, C.H., Schwartzberg, L., Zhen, B., Mangum, M., Leff, R., Tauer, K., Rosenberg, A., Pendergrass, K., Kaywin, P., Hainsworth, J., Greco, F.A., West, W.H. and Buckner, C.D. (1997) "High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of an outpatient treatment in community cancer centers", Bone Marrow Transplantation 20, 753–760.
   PubMed Web of Science ®Google Scholar
• van Besien, K., Tabocoff, J., Rodriguez, M., Andersson, B., Mehra, R., Przepiorka, D., Dimopoulos, M., Giralt, S., Suld, S., Khouri, I., Spitzer, G., Jagannath, S., Dicke, K., Le Maistre, C.F., Deisseroth, A., Cabanillas, F. and Champlin, R. (1995) "High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity", Bone Marrow Transplantation 15, 549–555.
   PubMed Web of Science ®Google Scholar
• Salar, A., Sierra, J., Candarillas, M., Caballero, M.D., Mann, J., Lahuerta, J.J., Garcia-Conde, J., Arranz, R., Leon, A., Zuazu, J., Garcia-Larana, J., Lopez-Guillermo, A., Sanz, MA., Granena, A., Garcia, J.C. and Conde, E. for the GEL/TAMO Spanish Cooperative Group (2001) "Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimen", Bone Marrow Transplantation 27, 405 —412.
   PubMed Web of Science ®Google Scholar